Sunshine Biopharma (SBFM) EPS (Basic) (2010 - 2026)

Sunshine Biopharma (SBFM) reported EPS (Basic) of -$0.25 for Q1 2026, up 43.18% on a YoY basis from -$0.17 in Q1 2025, and up 45.65% quarter-over-quarter from -$0.46 in Q4 2025.

Sunshine Biopharma (SBFM) EPS (Basic) (2010 - 2026) Analysis & Trends

Sunshine Biopharma has reported EPS (Basic) for 17 years, with the latest figure at -$0.25 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) rose 43.18% year-over-year to -$0.25; the trailing twelve-month figure through Mar 2026 stood at -$1.29 (up 74.35% YoY), and the FY2025 full-year result was -$1.44, up 80.33% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$0.25, up from -$0.46 in the prior quarter.
  • The five-year high for EPS (Basic) was $6.29 in Q4 2024, with the low at -$85.65 in Q4 2023.
  • Historically, EPS (Basic) has averaged -$13.25 across 5 years, with a median of -$0.46 in 2025.
  • Annual changes were most pronounced in 2023 — EPS (Basic) tumbled 237133.33% — and 2024, when it jumped 107.34%.
  • Sunshine Biopharma's EPS (Basic) stood at -$1.55 in 2022, then plunged by 5430.04% to -$85.65 in 2023, then jumped by 107.34% to $6.29 in 2024, then sank by 107.31% to -$0.46 in 2025, then surged by 45.65% to -$0.25 in 2026.
  • The last three EPS (Basic) figures came in at -$0.25 (Q1 2026), -$0.46 (Q4 2025), and -$0.19 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 0.32
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 1.42
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 6.32
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 0.02
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1.97
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 0.11
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -0.40
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.83
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -0.40
10 Sunshine Biopharma 11.70 Mn 4.79 Mn 2.18 Mn -0.25

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.25
Dec 31, 2025 -0.46
Sep 30, 2025 -0.19
Jun 30, 2025 -0.39
Mar 31, 2025 -0.44
Dec 31, 2024 6.29
Sep 30, 2024 -0.94
Jun 30, 2024 -9.94
Mar 31, 2024 -2.00
Dec 31, 2023 -85.65
Sep 30, 2023 -50.72
Jun 30, 2023 -71.17
Mar 31, 2023 -7.73
Dec 31, 2022 -1.55
Sep 30, 2022 0.08
Jun 30, 2022 -0.03
Mar 31, 2022 -0.23
Dec 31, 2021 0.97
Sep 30, 2021 -1.59
Jun 30, 2021 -1.21